Doctors urged to maintain secondary prevention post-CABG
Large Swedish study shows its importance in reducing mortality
Adhering to secondary prevention medicines long term after a coronary artery bypass graft (CABG) reduces mortality, investigators say.
Swedish researchers used population data to follow nearly 28,500 people (mean age 67) who underwent CABG between 2006 and 2015 and examine how income, education and adherence to secondary prevention affected mortality.
All patients included had survived for at least six months post-procedure and their take-up of prescriptions was tracked every three months thereafter for up to eight years.
Over a mean follow-up of 4.9